Market closed
Progyny/$PGNY
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Progyny
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
Ticker
$PGNY
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
565
Website
Progyny Metrics
BasicAdvanced
$1.5B
Market cap
26.25
P/E ratio
$0.63
EPS
1.46
Beta
-
Dividend rate
Price and volume
Market cap
$1.5B
Beta
1.46
52-week high
$42.08
52-week low
$13.93
Average daily volume
1.6M
Financial strength
Current ratio
2.583
Quick ratio
2.467
Long term debt to equity
3.741
Total debt to equity
4.355
Management effectiveness
Return on assets (TTM)
6.45%
Return on equity (TTM)
13.56%
Valuation
Price to earnings (TTM)
26.249
Price to revenue (TTM)
1.393
Price to book
3.29
Price to tangible book (TTM)
3.42
Price to free cash flow (TTM)
9.232
Growth
Revenue change (TTM)
18.33%
Earnings per share change (TTM)
28.49%
3-year revenue growth (CAGR)
36.04%
3-year earnings per share growth (CAGR)
-6.84%
What the Analysts think about Progyny
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Progyny stock.
Progyny Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Progyny Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Progyny News
AllArticlesVideos
Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman
GlobeNewsWire·11 hours ago
Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders
GlobeNewsWire·12 hours ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
Accesswire·4 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Progyny stock?
Progyny (PGNY) has a market cap of $1.5B as of November 09, 2024.
What is the P/E ratio for Progyny stock?
The price to earnings (P/E) ratio for Progyny (PGNY) stock is 26.25 as of November 09, 2024.
Does Progyny stock pay dividends?
No, Progyny (PGNY) stock does not pay dividends to its shareholders as of November 09, 2024.
When is the next Progyny dividend payment date?
Progyny (PGNY) stock does not pay dividends to its shareholders.
What is the beta indicator for Progyny?
Progyny (PGNY) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.